Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model

SIMPLE SUMMARY: In recent years, the development of immune checkpoint inhibitors, such as anti-PD‑1 and anti-PD-L1, proved to prolong melanoma patient survival and are now used in routine clinical practice. PD-L1 also represents a potent biomarker for in vivo molecular imaging using radiolabeled ant...

詳細記述

保存先:
書誌詳細
出版年:Cancers (Basel)
主要な著者: Capitao, Marisa, Perrin, Justine, Simon, Sylvain, Gouard, Sébastien, Chouin, Nicolas, Bruchertseifer, Frank, Morgenstern, Alfred, Rbah-Vidal, Latifa, Chérel, Michel, Scotet, Emmanuel, Labarrière, Nathalie, Guilloux, Yannick, Gaschet, Joëlle
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8000940/
https://ncbi.nlm.nih.gov/pubmed/33809167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061256
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料